ProPharma Group Revenue and Competitors
Estimated Revenue & Valuation
- ProPharma Group's estimated annual revenue is currently $787.9M per year.
- ProPharma Group's estimated revenue per employee is $321,600
- ProPharma Group's total funding is $8.6M.
- ProPharma Group has 2450 Employees.
- ProPharma Group grew their employee count by 169% last year.
ProPharma Group Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is ProPharma Group?
Xendo, Sofus Regulatory Affairs, and SOLUTIONS in Health are now ProPharma Group. Visit our website to learn more. ProPharma Group is an industry leader providing life science consulting, medical information, pharmacovigilance, and regulatory affairs services to the pharmaceutical, biotechnology, and medical device industries. We enable clients to deliver their products to patients in the most safe, compliant, and timely manner possible. Backed by years of experience, our highly trained team understands the needs companies have in this heavily regulated environment. ProPharma Group's experts custom tailor solutions for each of our clients based upon their unique needs and goals. By creating an integrated compliance solution, ProPharma Group is your global, single source for the insights and services needed to maintain the highest level of value and patient safety throughout the product lifecycle. We are headquartered in Overland Park, Kansas with offices across the country, and around the world.keywords:N/A
Number of Employees
Employee Growth %
ProPharma Group News
ProPharma Group Holdings, LLC 13.12. SGS S.A. 13.13. SIRO Clinpharm Private Limited 13.14. Syneos Health, Inc.
ProPharma Group is the global, independent, single-source provider of regulatory, clinical and compliance services serving pharmaceutical,...
“This is a powerful combination of two highly complementary businesses,” said Michael Stomberg, CEO of ProPharma Group. “We are confident this acquisition will come as a value-added partnership to our combined client base." OVERLAND PARK, Kan. (PRWEB) October 06, 2021 ProPharma Group, a portfo ...
“We look forward to the next phase of growth as we continue on our mission and higher purpose to improve patient health and safety, said Michael Stomberg, ProPharma Group’s CEO. OVERLAND PARK, Kan. (PRWEB) September 02, 2021 ProPharma Group, a portfolio company of Odyssey Investment Partners, ...
“This acquisition continues to strengthen ProPharma Group’s position as the leading global provider of regulatory and compliance consulting, clinical research, pharmacovigilance, and medical information services," said Dawn Sherman, ProPharma Group's CEO. OVERLAND PARK, Kan. (PRWEB) August 10, ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|